other material
confidence high
sentiment neutral
materiality 0.60
Sigyn Therapeutics reports conversion of $1.32M debentures into 7.3M shares
Sigyn Therapeutics, Inc.
- Holders converted $1,322,200 of Original Issue Discount Senior Convertible Debentures at $0.18/share.
- Company issued 7,300,342 shares of common stock between Oct 20-25, 2023.
- Outstanding shares increased from 44,231,402 to 51,531,744, a dilution of ~16.5%.
- No cash proceeds were received; debt was extinguished upon conversion.